Hematology Diagnostics Market Research Report, by Product Type (Hematology Analyzer, Flow Cytometer, Consumable), Tests (Hemoglobinopathy, Leukemia Phenotyping), End-User (Hospitals & Clinics, Diagnostic Laboratories) – Forecast Till 2027
ID: MRFR/LS/4801-HCR | | Region: Global | 100 pages
Hematology Diagnostics Market Scenario
Hematology Diagnostics Market is expected to reach USD 8.50 Billion, at a CAGR of 5% forecast period 2020-2027
Hematology is the branch of science that deals with cause, prognosis, treatment, and prevention of blood disorders. The hematology diagnostics market is expected to witness tremendous growth owing to the rising prevalence of blood disorders and technological advancements. The Leukemia & Lymphoma Society (LLS) predicted 174,250 new cases of leukemia, lymphoma or myeloma in 2018 in the U.S. Other key factors like increase in the prevalence of genetic diseases, the rise in hematological testing, growing blood transfusions and donations and increasing adoption of automated hematology analyzers are contributing towards the growth of the market. According to the Centers for Disease Control and Prevention in 2017, approximately 70,000 to 100,000 Americans have sickle cell disease which is genetic blood disorder.
However, factors such as high cost of diagnostics, poor healthcare insurance coverage for diagnostic procedures and lack of awareness are expected to restrict the hematology diagnostics market growth during the forecast period.
Segmentation
The hematology diagnostics market is segmented on the basis of product type, tests, and end-user. The hematology diagnostics market, by product type categorized into hematology analyzers, flow cytometers, and consumables. Hematology analyzers category includes fully-automated hematology analyzers and semi-automated hematology analyzers. Consumables segment includes reagents, stains, controls & calibrators, and others. Tests category is further segmented into anemia, hemoglobinopathy, leukemia/lymphoma phenotyping, hematology pathophysiology, complete blood count (CBC) and others. On the basis of end-user, the market is segmented into hospitals and clinics, ambulatory surgical centers, diagnostic laboratories, academic institutes and others.
On the basis of region, the hematology diagnostics market is segmented into the Americas, Europe, Asia-Pacific, and the Middle East and Africa. The Americas is sub-segmented into North America and South America. The North American region is further segmented into the U.S. and Canada. The European region is divided into two, namely, Western Europe and Eastern Europe. Western Europe is further classified into Germany, Italy, France, the UK, Spain, and the rest of Western Europe. The Asia-Pacific region is sub-segmented into Japan, China, India, Australia, the Republic of Korea, and the rest of Asia-Pacific. The Middle Eastern and African region is sub-segmented into the United Arab Emirates, Saudi Arabia, Oman, Kuwait, Qatar, and the rest of the Middle East and Africa.
Regional Market Summary
Hematology Diagnostics Market Share (%), by Region, 2017
Sources: Statista, the Centers for Disease Control and Prevention, the World Hematology Congress, Leukemia & Lymphoma Society (LLS)
The hematology diagnostics market is dominated by North America owing to the rising prevalence of blood diseases. According to Statista in 2016, 33% of all the Americans were diagnosed with hemophilia A were between 19-44 years of age. The presence of major market players such as Abbott Laboratories Danaher, Bio-Rad Laboratories, and others within the region also influences the market growth. Other factors like increasing healthcare expenditure, technological advancements within the population drive the market growth in this region.
It is estimated that Europe stood second in the global hematology diagnostics market owing to increasing hematology research within this region. The 16th World Hematology Congress will be conducted in March 2019 in London, UK to discuss the diagnosis and treatment of hematology, blood disorders, hematologic oncology, hematologic disorders, and immunohematology. Thus, increasing hematology research and government initiatives within this region influences the growth of this market in this region.
Asia-Pacific was projected to be the fastest growing region for the global hematology diagnostics market in 2017. The market is expected to witness growth owing to the rising prevalence of blood disorders and genetic diseases. The South Asians are more vulnerable to genetic disorders due to consanguineous marriages or marrying within the same ethnicity, community, caste, etc.
The Middle East and Africa holds the least share in the global hematology diagnostics market due to the presence of stringent government policies and poor economies. However, the market is expected to witness growth due to high investments by the private market players in the Middle East. Also, the growing prevalence of genetic blood disorders and rising government initiatives to improve the healthcare sector within the region contribute to market growth.
Market Segmentation and Key Market Players
Hematology Diagnostics Market, by Product Type
- Hematology Analyzers
- Fully-automated Hematology Analyzers
- Semi-automated Hematology Analyzers
- Flow Cytometers
- Consumables
- Reagents
- Stains
- Controls & Calibrators
- Others
Hematology Diagnostics Market, by Tests
- Anemia
- Hemoglobinopathy
- Leukemia/Lymphoma Phenotyping
- Hematology pathophysiology
- Complete blood count (CBC)
- Others
Hematology Diagnostics Market, by End-User
- Hospitals & Clinics
- Ambulatory Surgical Centers
- Diagnostic Laboratories
- Academic Institutes
- Others
Hematology Diagnostics Market, by Region
- Americas
- Europe
- Asia-Pacific
- Middle East & Africa
Hematology Diagnostics Market, by Key Players
- Sysmex (Japan)
- Danaher (US)
- Nihon Kohden (Japan)
- Siemens (Germany)
- Abbott Laboratories (US)
- Boule Diagnostics (Sweden)
- HORIBA (Japan)
- Bio-Rad Laboratories (US)
- BioSystems (Spain)
- Diatron (Hungary)
- Drew Scientific (US)
- EKF Diagnostics (UK)
- Mindray (China)
- Ortho Clinical Diagnostics (US)
- Roche (Switzerland)
Intended Audience
- Pharmaceutical companies
- Biotechnological institutes
- Government and private laboratories
- Research and Development (R&D) companies
- Medical research laboratories
- Market research and consulting service providers
Report Scope:
| Report Attribute/Metric | Details |
|---|---|
| Market Size | 2027: USD 8.50 Billion |
| CAGR | 5% (2020-2027) |
| Base Year | 2019 |
| Forecast Period | 2020-2027 |
| Historical Data | 2018 |
| Forecast Units | Value (USD Billion) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | Product Type, Tests, and End-user |
| Geographies Covered | North America, Europe, Asia-Pacific, and Rest of the World (RoW) |
| Key Vendors | Sysmex (Japan), Danaher (US), Nihon Kohden (Japan), Siemens (Germany), Abbott Laboratories (US), Boule Diagnostics (Sweden), HORIBA (Japan), Bio-Rad Laboratories (US), BioSystems (Spain), Diatron (Hungary), Drew Scientific (US), EKF Diagnostics (UK), Mindray (China), Ortho Clinical Diagnostics (US), Roche (Switzerland) |
| Key Market Opportunities |
|
| Key Market Drivers |
|
Frequently Asked Questions (FAQ) :
Hematology Diagnostics Market is to reach at USD 8.50 Billion by 2027
Hematology Diagnostics Market is expected to register a CAGR of 5% during the forecast period of 2020 to 2027
key factors like increase in the prevalence of genetic diseases, the rise in hematological testing, growing blood transfusions and donations and increasing adoption of automated hematology analyzers are contributing towards the growth of the market.
The hematology diagnostics market is dominated by North America owing to the rising prevalence of blood diseases.
The central contenders in the hematology diagnostics market globally are Ortho Clinical Diagnostics (US), Danaher (US), Siemens (Germany), Boule Diagnostics (Sweden), HORIBA (Japan), Abbott Laboratories (US), EKF Diagnostics (UK), Bio-Rad Laboratories (US), BioSystems (Spain), Sysmex (Japan), Diatron (Hungary), Nihon Kohden (Japan), Drew Scientific (US), Mindray (China), and Roche (Switzerland), and other.
TABLE OF CONTENT
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope of the Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
Chapter 5. Market Factor Analysis
5.1 Porter’s Five Forces Analysis
5.1.1 Bargaining Power of Suppliers
5.1.2 Bargaining Power of Buyers
5.1.3 Threat of New Entrants
5.1.4 Threat of Substitutes
5.1.5 Intensity of Rivalry
5.2 Value Chain Analysis
5.3 Investment Feasibility Analysis
5.4 Pricing Analysis
Chapter 6. Global Hematology Diagnostics Market, by Product Type
6.1 Introduction
6.2 Hematology Analyzers
6.2.1 Fully-automated Hematology Analyzers
6.2.2 Semi-automated Hematology Analyzers
6.3 Flow Cytometers
6.4 Consumables
6.4.1 Reagents
6.4.2 Stains
6.4.3 Controls & Calibrators
6.5 Others
Chapter 7. Global Hematology Diagnostics Market, by Tests
7.1 Introduction
7.2 Anemia
7.3 Hemoglobinopathy
7.4 Leukemia/Lymphoma Phenotyping
7.5 Hematology pathophysiology
7.6 Complete Blood Count (CBC)
7.7 Others
Chapter 8. Global Hematology Diagnostics Market, by End-User
8.1 Introduction
8.2 Hospitals & Clinics
8.3 Ambulatory Surgical Centers
8.4 Diagnostic Laboratories
8.5 Academic Institutes
8.6 Others
Chapter 9. Global Hematology Diagnostics Market, by Region
9.1 Introduction
9.2 America
9.2.1 North America
9.2.1.1 US
9.2.1.2 Canada
9.2.2 South America
9.3 Europe
9.3.1 Western Europe
9.3.1.1 Germany
9.3.1.2 France
9.3.1.3 Italy
9.3.1.4 Spain
9.3.1.5 UK
9.3.1.6 Rest of Western Europe
9.3.2 Eastern Europe
9.4 Asia-Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 Republic of Korea
9.4.6 Rest of Asia-Pacific
9.5 Middle East & Africa
9.5.1 United Arab Emirates
9.5.2 Saudi Arabia
9.5.3 Oman
9.5.4 Kuwait
9.5.5 Qatar
9.5.6 Rest of the Middle East & Africa
Chapter 10. Company Landscape
10.1 Introduction
10.2 Market Share Analysis
10.3 Key Development & Strategies
10.3.1 Key Developments
Chapter 11 Company Profiles
11.1 Sysmex
11.1.1 Company Overview
11.1.2 Type Overview
11.1.3 Financials
11.2.4 Key Developments
11.1.5 SWOT Analysis
11.2 Danaher
11.2.1 Company Overview
11.2.2 Type Overview
11.2.3 Financial Overview
11.2.4 Key Developments
11.2.5 SWOT Analysis
11.3 Nihon Kohden
11.3.1 Company Overview
11.3.2 Type Overview
11.3.3 Financial Overview
11.3.4 Key Development
11.3.5 SWOT Analysis
11.4 Siemens
11.4.1 Company Overview
11.4.2 Type/Business Segment Overview
11.4.3 Financial Overview
11.4.4 Key Development
11.4.5 SWOT Analysis
11.5 Abbott Laboratories
11.5.1 Company Overview
11.5.2 Type Overview
11.5.3 Financial overview
11.5.4 Key Developments
11.5.5 SWOT Analysis
11.6 Boule Diagnostics
11.6.1 Company Overview
11.6.2 Type Overview
11.6.3 Financial Overview
11.6.4 Key Developments
11.6.5 SWOT Analysis
11.7 HORIBA
11.7.1 Overview
11.7.2 Type Overview
11.7.3 Financials
11.7.4 Key Developments
11.7.5 SWOT Analysis
11.8 Bio-Rad Laboratories
11.8.1 Overview
11.8.2 Type Overview
11.8.3 Financials
11.8.4 Key Developments
11.8.5 SWOT Analysis
11.9 BioSystems
11.9.1 Overview
11.9.2 Type Overview
11.9.3 Financials
11.9.4 Key Developments
11.9.5 SWOT Analysis
11.10 Diatron
11.10.1 Overview
11.10.2 Type Overview
11.10.3 Financials
11.10.4 Key Developments
11.10.5 SWOT Analysis
11.11 EKF Diagnostics
11.11.1 Overview
11.11.2 Type Overview
11.11.3 Financials
11.11.4 Key Developments
11.11.5 SWOT Analysis
11.12 Drew Scientific
11.12.1 Overview
11.12.2 Type Overview
11.12.3 Financials
11.12.4 Key Developments
11.12.5 SWOT Analysis
11.13 Mindray
11.13.1 Overview
11.13.2 Type Overview
11.13.3 Financials
11.13.4 Key Developments
11.13.5 SWOT Analysis
11.14 Ortho Clinical Diagnostics
11.13.1 Overview
11.13.2 Type Overview
11.13.3 Financials
11.13.4 Key Developments
11.13.5 SWOT Analysis
11.15 Roche
11.13.1 Overview
11.13.2 Type Overview
11.13.3 Financials
11.13.4 Key Developments
11.13.5 SWOT Analysis
11.16 Others
Chapter 12 Appendix
LIST OF TABLES
Table 1 Hematology Diagnostics Market Industry Synopsis, 2020-2027
Table 2 Global Hematology Diagnostics Market Estimates & Forecast, 2020-2027, (USD Million)
Table 3 Global Hematology Diagnostics Market, by Region, 2020-2027, (USD Million)
Table 4 Global Hematology Diagnostics Market, by Product Type, 2020-2027, (USD Million)
Table 5 Global Hematology Diagnostics Market, by Tests, 2020-2027, (USD Million)
Table 6 Global Hematology Diagnostics Market, by End-User, 2020-2027, (USD Million
Table 7 North America Hematology Diagnostics Market, by Product Type, 2020-2027, (USD Million)
Table 8 North America Hematology Diagnostics Market, by Tests, 2020-2027, (USD Million)
Table 9 North America Hematology Diagnostics Market, by End-User, 2020-2027, (USD Million)
Table 10 US Hematology Diagnostics Market, by Product Type, 2020-2027, (USD Million)
Table 11 US Hematology Diagnostics Market, by Tests, 2020-2027, (USD Million)
Table 12 US Hematology Diagnostics Market, by End-User, 2020-2027, (USD Million)
Table 13 Canada Hematology Diagnostics Market, by Product Type, 2020-2027, (USD Million)
Table 14 Canada Hematology Diagnostics Market, by Tests, 2020-2027, (USD Million)
Table 15 Canada Hematology Diagnostics Market, by End-User, 2020-2027, (USD Million)
Table 16 South America Hematology Diagnostics Market, by Product Type, 2020-2027, (USD Million)
Table 17 South America Hematology Diagnostics Market, by Tests, 2020-2027, (USD Million)
Table 18 South America Hematology Diagnostics Market, by End-User, 2020-2027, (USD Million)
Table 19 Europe Hematology Diagnostics Market, Product Type, 2020-2027, (USD Million)
Table 20 Europe Hematology Diagnostics Market, by Tests, 2020-2027, (USD Million)
Table 21 Europe Hematology Diagnostics Market, by End-User, 2020-2027, (USD Million)
Table 22 Western Europe Hematology Diagnostics Market, by Product Type, 2020-2027, (USD Million)
Table 23 Western Europe Hematology Diagnostics Market, by Tests, 2020-2027, (USD Million)
Table 24 Western Europe Hematology Diagnostics Market, by End-User, 2020-2027, (USD Million)
Table 25 Eastern Europe Hematology Diagnostics Market, by Product Type, 2020-2027, (USD Million)
Table26 Eastern Europe Hematology Diagnostics Market, by Tests, 2020-2027, (USD Million)
Table 27 Eastern Europe Hematology Diagnostics Market, by End-User, 2020-2027, (USD Million)
Table 28 Asia-Pacific Hematology Diagnostics Market, by Product Type, 2020-2027, (USD Million)
Table 29 Asia-Pacific Hematology Diagnostics Market, by Tests, 2020-2027, (USD Million)
Table 30 Asia-Pacific Hematology Diagnostics Market, by End-User, 2020-2027, (USD Million)
Table 31 The Middle East & Africa Hematology Diagnostics Market, by Product Type, 2020-2027, (USD Million)
Table 32 The Middle East & Africa Hematology Diagnostics Market, by Tests, 2020-2027, (USD Million)
Table 33 The Middle East & Africa Hematology Diagnostics Market, by End-User, 2020-2027, (USD Million)
LIST OF FIGURES
Figure 1 Research Process
Figure 2 Segmentation for Global Hematology Diagnostics Market
Figure 3 Market Dynamics for Global Hematology Diagnostics Market
Figure 4 Global Hematology Diagnostics Market Share, by Product Type 2020
Figure 5 Global Hematology Diagnostics Market Share, by Tests 2020
Figure 6 Global Hematology Diagnostics Market Share, by End-User, 2020
Figure 7 Global Hematology Diagnostics Market Share, by Region, 2020
Figure 8 North America Hematology Diagnostics Market Share, by Country, 2020
Figure 9 Europe Hematology Diagnostics Market Share, by Country, 2020
Figure 10 Asia-Pacific Hematology Diagnostics Market Share, by Country, 2020
Figure 11 Middle East & Africa Hematology Diagnostics Market Share, by Country, 2020
Figure 12 Global Hematology Diagnostics Market: Company Share Analysis, 2020 (%)
Figure 13 SYSMEX: Key Financials
Figure 14 SYSMEX: Segmental Revenue
Figure 15 SYSMEX: Geographical Revenue
Figure 16 Danaher: Key Financials
Figure 17 Danaher: Segmental Revenue
Figure 18 Danaher: Geographical Revenue
Figure 19 Nihon Kohden: Key Financials
Figure 20 Nihon Kohden: Segmental Revenue
Figure 21 Nihon Kohden: Geographical Revenue
Figure 22 Siemens: Key Financials
Figure 23 Siemens: Segmental Revenue
Figure 24 Siemens: Geographical Revenue
Figure 25 Abbott Laboratories: Key Financials
Figure 26 Abbott Laboratories: Segmental Revenue
Figure 27 Abbott Laboratories: Geographical Revenue
Figure 28 Boule Diagnostics Laboratories: Key Financials
Figure 29 Boule Diagnostics Laboratories: Segmental Revenue
Figure 30 Boule Diagnostics Laboratories: Geographical Revenue
Figure 31 HORIBA: Key Financials
Figure 32 HORIBA: Segmental Revenue
Figure 33 HORIBA: Geographical Revenue
Figure 34 Bio-Rad Laboratories: Key Financials
Figure 35 Bio-Rad Laboratories: Segmental Revenue
Figure 36 Bio-Rad Laboratories: Geographical Revenue
Figure 37 BioSystems: Key Financials
Figure 38 BioSystems: Segmental Revenue
Figure 39 BioSystems: Geographical Revenue
Figure 40 Diatron: Key Financials
Figure 41 Diatron: Segmental Revenue
Figure 42 Diatron: Geographical Revenue
Figure 46 Drew Scientific: Key Financials
Figure 47 Drew Scientific: Segmental Revenue
Figure 48 Drew Scientific: Geographical Revenue
Figure 49 Mindray: Key Financials
Figure 50 Mindray: Segmental Revenue
Figure 51 Mindray: Geographical Revenue
Figure 52 Ortho Clinical Diagnostics: Key Financials
Figure 53 Ortho Clinical Diagnostics: Segmental Revenue
Figure 54 Ortho Clinical Diagnostics: Geographical Revenue
Figure 55 Roche: Key Financials
Figure 56 Roche: Segmental Revenue
Figure 57 Roche: Geographical Revenue